| Effect |
Chromosome |
Odds Ratio Estimate |
Lower CL* |
Upper CL |
| TFF1 Loss vs. Normal |
21q22.3 |
3.019 |
1.514 |
6.02 |
| TFF1 Gain vs. Normal |
|
0.08 |
0.024 |
0.268 |
| PRKDC Loss vs. Normal |
8q11 |
0.276 |
0.11 |
0.692 |
| PRKDC Gain vs. Normal |
|
5.449 |
2.09 |
14.206 |
| MYC Loss vs. Normal |
8q24.12 |
0.221 |
0.097 |
0.503 |
| MYC Gain vs. Normal |
|
2.218 |
1.136 |
4.332 |
| LTA Loss vs. Normal |
6p21.3 |
2.156 |
1.172 |
3.965 |
| LTA Gain vs. Normal |
|
0.266 |
0.108 |
0.655 |
| IL2 Loss vs. Normal |
4q26 |
3.697 |
1.774 |
7.705 |
| IL2 Gain vs. Normal |
|
0.149 |
0.055 |
0.407 |
| FGFR1 Loss vs. Normal |
8p21 |
0.275 |
0.126 |
0.598 |
| FGFR1 Gain vs. Normal |
|
5.555 |
1.689 |
18.267 |
| CTNNB1 Loss vs. Normal |
3p22 |
2.682 |
1.394 |
5.162 |
| CTNNB1 Gain vs. Normal |
|
0.323 |
0.147 |
0.71 |
| CDKN2A Loss vs. Normal |
9p21 |
1.845 |
1.013 |
3.362 |
| CDKN2A Gain vs. Normal |
|
0.14 |
0.056 |
0.35 |
*CL: Confidence Limit |